Literature DB >> 36055807

Comment on "Grip strength as a predictor of disease severity in hospitalized COVID-19 patients".

.   

Abstract

Entities:  

Year:  2022        PMID: 36055807      PMCID: PMC9404226          DOI: 10.1016/j.hrtlng.2022.08.020

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   3.149


× No keyword cloud information.

To the editor,

I have read with keen interest the manuscript titled “Grip strength as a predictor of disease severity in hospitalized COVID-19 patients” by Kara et al. in which the authors conclude that low grip strength increases the severity of COVID-19 independent of other factors. However, there are a few concerns that I would like to raise. First of all, it is a single center study, and the subjects are recruited from Turkey; therefore, due to differences in racial makeup and genetic background, caution needs to be exercised when extrapolating the results to other countries. Additionally, there is lack of mention regarding the parameters that represents muscle mass; thus, no association can be drawn between sarcopenia and the COVID-19 disease severity. Furthermore, due to the cross-sectional nature of the study, no firm conclusions regarding causal inference can be drawn. Also, as there is no follow-up, we are unable to compare the results to those of other researches that looked at long-term consequences. Some other factors that influence grip strength yet were not addressed in this study are body construct including height, bone mineral density, hand size, upper arm circumference and socioeconomic variables including occupation, social status, and lifestyle. Moreover, it has been discovered that grip strength varies throughout the day. For instance, this research demonstrates that grip strength increases between 6.00 am and 9.00 am whereas it decreases between 8.00 pm and 4.00 am. Although it is not considered in this study, depression is another factor linked to a higher chance of losing muscular strength. Finally, it is a good opportunity to address a relatively less talked about concept of dynapenia which is an age-related muscle weakness not brought on by neurological or muscular disorders. Older persons who have dynapenia are more likely to experience functional restrictions and mortality.

Declaration of Competing Interest

The author declares no competing declaration of interest.
  6 in total

1.  Depressed mood and body mass index as predictors of muscle strength decline in old men.

Authors:  T Rantanen; B W Penninx; K Masaki; T Lintunen; D Foley; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-06       Impact factor: 5.562

Review 2.  What is dynapenia?

Authors:  Brian C Clark; Todd M Manini
Journal:  Nutrition       Date:  2012-05       Impact factor: 4.008

3.  Factors affecting maximal momentary grip strength.

Authors:  S Martin; G Neale; M Elia
Journal:  Hum Nutr Clin Nutr       Date:  1985-03

4.  Grip strength as a predictor of disease severity in hospitalized COVID-19 patients.

Authors:  Özgür Kara; Murat Kara; Mustafa Emre Akın; Levent Özçakar
Journal:  Heart Lung       Date:  2021-06-11       Impact factor: 2.210

5.  Association Between Low Handgrip Strength and 90-Day Mortality Among Older Chinese Inpatients: A National Multicenter Prospective Cohort Study.

Authors:  Xiao-Ming Zhang; Jing Jiao; Chen Zhu; Na Guo; Ying Liu; Dongmei Lv; Hui Wang; Jingfen Jin; Xianxiu Wen; Shengxiu Zhao; Xinjuan Wu; Tao Xu
Journal:  Front Nutr       Date:  2021-06-29

6.  Evaluation of factors influencing grip strength in elderly koreans.

Authors:  Jung Eun Lee; Ki Woong Kim; Nam-Jong Paik; Hak Chul Jang; Chong Bum Chang; Goo Hyun Baek; Young Ho Lee; Hyun Sik Gong
Journal:  J Bone Metab       Date:  2012-11-16
  6 in total
  1 in total

1.  Authors response to: Comment on "Grip strength as a predictor of disease severity in hospitalized COVID-19 patients".

Authors:  Özgür Kara; Murat Kara; Mustafa Emre Akın; Levent Özçakar
Journal:  Heart Lung       Date:  2022-09-14       Impact factor: 3.149

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.